Back to School: How biopharma can reboot drug development. Access exclusive analysis here
PANC gained $0.63 (33%) to $2.52 on Friday after reporting late Thursday preliminary data from
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury